Fulcrum Therapeutics, Inc.
Pharmaceutical company · Cambridge, Massachusetts, United States · Nasdaq: FULC
Fulcrum Therapeutics, Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2015. Its shares trade on Nasdaq under the ticker FULC. It has reported private securities offerings to the US SEC, most recently $68 million sold in a notice filed in 2020.
Fulcrum Therapeutics at a glance
What does Fulcrum Therapeutics do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $68.5 million sold (2020).
Frequently asked questions about Fulcrum Therapeutics
Where is Fulcrum Therapeutics headquartered?
Fulcrum Therapeutics, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Fulcrum Therapeutics do?
Fulcrum Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Fulcrum Therapeutics a public company?
Yes. Fulcrum Therapeutics, Inc. trades on Nasdaq under the ticker FULC.
When was Fulcrum Therapeutics founded?
The earliest incorporation on record for Fulcrum Therapeutics, Inc. is in 2015, according to public company registers.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.